HighTide Biopharma Pty Ltd

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

A Study of HTD1801 in Healthy Subjects

Phase 1

Completed

Conditions: Primary Sclerosing Cholangitis

Interventions: Drug: HTD1801

First Posted Date: 2017-04-04

Last Posted Date: 2020-07-27

Lead Sponsor: HighTide Biopharma Pty Ltd

Target Recruit Count: 32

Registration Number: NCT03099603

Locations: 🇦🇺
Nucleus Network Limited, Melbourne, Victoria, Australia

Study of HTD4010 in Healthy Volunteers

Phase 1

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: HTD4010

First Posted Date: 2015-09-02

Last Posted Date: 2020-07-27

Lead Sponsor: HighTide Biopharma Pty Ltd

Target Recruit Count: 32

Registration Number: NCT02538848

Locations: 🇦🇺
Linear Clinical Research Limited, Perth, Australia

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy